期刊文献+

紫苏醇亚微乳在大鼠体内的组织分布研究 被引量:2

Tissue Distribution of Perillyl Alcohol Submicron Emulsions in Rats
原文传递
导出
摘要 以雌性大鼠为动物模型,分别尾静脉注射紫苏醇亚微乳(试验组)和紫苏醇溶液(对照组),剂量均为65 mg/kg。采用HPLC法测定血浆和组织样品中的紫苏醇及其代谢产物紫苏酸的含量,以考察二者在大鼠血浆和各组织(心、肝、脾、肺、肾、脑、胃、子宫、卵巢和乳腺)中的分布特点,并以相对摄取率来评价靶向性。结果表明,试验组在肺、肝、肾和血浆中紫苏醇的浓度高于对照组,紫苏酸的浓度无显著性差异。相对摄取率的数据显示,紫苏醇在肝、脾、肺及肾组织中有蓄积作用。 The perillyl alcohol submicron emulsions(test group)and its solution(reference group)were injected by caudal vein to female rats at 65 mg/kg.The concentrations of perillyl alcohol and its metabolite,perillic acid,in plasma and several tissues such as heart,liver,spleen,lung,kidney,brain,stomach,uterus,ovary and mammary gland were determined by HPLC to investigate the distribution of two compounds.The relative tissue exposure(re) values of the above tissues were calculated to evaluate the targeting effects of the perillyl alcohol submicron emulsions.The results showed that perillyl alcohol concentration of test group in lung,liver,kidney and plasma was higher than that of reference group,and perillic acid concentrations of two groups in plasma and tissues had no significant difference.The relative tissue exposure result indicated that perillyl alcohol accumulated in liver,spleen,lung and kidney.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2010年第11期841-844,共4页 Chinese Journal of Pharmaceuticals
基金 2009年河南省重点科技攻关资助项目(092102310028)
关键词 紫苏醇 紫苏酸 亚微乳 组织分布 高效液相色谱 perillyl alcohol perillic acid submicron emulsion tissue distribution HPLC
  • 相关文献

参考文献10

  • 1Crowell PL. Prevention and therapy of cancer by dietary monoterpenes [J] . JNutr, 1999, 129 (3) : 775S-778S.
  • 2Bailey HH, Attia S, Love RR, et al. Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer [J]. Cancer Chemother Pharmacol, 2008, 62(1): 149-157.
  • 3Meadows SM, Mulkerin D, Berlin J, et al. Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer [J]. Int J Gastrointest Cancer, 2002, 32 (2-3) : 125-128.
  • 4Gupta A, Myrdal PB. Development of a perillyl alcohol topical cream formulation [J]. Int J Pharm, 2004, 269 (2) : 373-383.
  • 5Zhang Z, Chen H, Chan KK, et al. Gas chromatographicmass spectrometric analysis of perillyl alcohol and metabolites in plasma [J]. J Chromatogr B Biomed Sci Appl, 1999, 728(1): 85-95.
  • 6Ripple GH, Gould MN, Stewart JA, et al. Phase I clinical trial of perillyl alcohol administered daily [J]. Clin Cancer Res, 1998, 4(5): 1159-1164.
  • 7华海婴,刘琳,赵永星,张振中.紫苏醇亚微乳剂的制备及其HPLC法测定[J].中国医药工业杂志,2008,39(6):447-449. 被引量:9
  • 8华海婴,赵永星,刘琳.紫苏醇亚微乳中药物的相分布和体外释放研究[J].中国医药工业杂志,2009,40(1):32-35. 被引量:5
  • 9Mills J J, Chari RS, Boyer IJ, et al. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol [J]. Cancer Res, 1995, 55(5): 979-983.
  • 10Xu M, Floyd HS, Greth SM, et al. Perillyl alcohol-mediated inhibition of lung cancer cell line proliferation: potential mechanisms for its chemotherapeutic effects [J]. Toxicol ApplPharmacol, 2004, 195 (2):232-246.

二级参考文献21

  • 1程司堃,王茹,李晓晔,张晓楠,孙晓莉.毛细管气相色谱法测定紫苏提取液中紫苏醇含量[J].医药导报,2005,24(6):522-523. 被引量:3
  • 2Meadows SM, Mulkerin D, Berlin J, et al. Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer [J]. Int J Gastrointest Cancer, 2003, 32 (2-3): 125-128.
  • 3Bailey HH, Attia S, Love RR, et al. Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer [J]. Cancer Chemother Pharmacol, 2008, 62(1): 149-157.
  • 4Tamilvanan S. Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems [J]. Prog Lipid Res, 2004, 43 (6) : 489-533.
  • 5Hashida M, Kawakami S, Yamashita F. Lipid carrier systems for targeted drug and gene delivery [J]. Chem Pharm Bull (Tokyo), 2005, 53 (8): 871-880.
  • 6Han J, Washington C. Partition of antimicrobial additives in an intravenous emulsion and their effect on emulsion physical stability [J]. IntJPharm, 2005, 288 (2) : 263-271.
  • 7Levy MY, Benita S. Drug release from submicronized o/w emulsion: a new in vitro kinetic evaluation model [J]. Int J Pharm, 1990, 66(1-3): 29-37.
  • 8Jumaa M, Muller BW. Physicochemical properties of chitosan-lipid emulsions and their stability during the autoclaving process [J]. Int JPharm, 1999, 183 (2): 175-184.
  • 9Ogawa S, Decker EA, McClements DJ. Production and characterization of o/w emulsions containing droplets stabilized by lecithin-chitosan-pectin mutilayered membranes [J]. JAgricFoodChem, 2004, 52(11): 3595-3600.
  • 10Crowell PL. Prevention and therapy of cancer by dietary monoterpenes [J]. JNutr, 1999, 129 (3) : 775S-778S.

共引文献9

同被引文献6

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部